Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000192636 | SCV000247829 | uncertain significance | not specified | 2015-07-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000766665 | SCV000617187 | uncertain significance | not provided | 2023-11-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000766665 | SCV001068447 | likely benign | not provided | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252047 | SCV002523558 | likely benign | See cases | 2020-02-22 | criteria provided, single submitter | clinical testing | ACMG classification criteria: BP1, BP4 |
Ambry Genetics | RCV002517945 | SCV003733560 | likely benign | Inborn genetic diseases | 2022-05-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003937696 | SCV004764286 | likely benign | LAMC3-related disorder | 2019-11-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |